Presentations to highlight JADE101’s preclinical safety profile and translational framework guiding its clinical development in IgA ...

Kezar Life Sciences faces FDA delays for AIH drug trials, implements restructuring, and explores strategic alternatives amid ...

A Taiwan trial found a plant-based serum boosted hair density by 25% in eight weeks using growth factors and natural vesicles ...

Kezar Life Sciences (KZR) announced regulatory updates and the initiation of a process to explore a full range of strategic alternatives focused ...

Scientists discovered that lean pork builds muscle more effectively post-workout than high-fat pork, even with identical ...

Help advance research on the brain-body connection in youth with/without anxiety, OCD, and anorexia. Participants will be compensated up to $200.

Although experts may disagree on how to classify neurogenic rosacea pain, they advise dermatologists to get more comfortable ...

A new scientific statement published today in the American Heart Association's flagship journal Circulation states that significant differences exist in cardiac rehabilitation access, participation ...

NRIX stock is rated Strong Buy as bexobrutideg advances in CLL trials. See here for NRIX stock's milestones, market potential ...

Following Phase 3 trials, the drug candidate manufacturer can apply for a New Drug Application (NDA) from the FDA. The FDA ...

In late September, Moscow municipal official Sergei Martyanov sent a series of text messages to his subordinates: "Colleagues!!!... What is this sabotage???" ...

AstraZeneca has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday.